These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9341895)

  • 1. Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment.
    Junker K; Thomas M; Schulmann K; Klinke F; Bosse U; Müller KM
    J Cancer Res Clin Oncol; 1997; 123(9):469-77. PubMed ID: 9341895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading of tumor regression in non-small cell lung cancer : morphology and prognosis.
    Junker K; Langner K; Klinke F; Bosse U; Thomas M
    Chest; 2001 Nov; 120(5):1584-91. PubMed ID: 11713138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neoadjuvant therapy in non-small cell lung cancer. Prognostic impact of "mediastinal downstaging"].
    Langner K; Thomas M; Klinke F; Bosse U; Heinecke A; Müller KM; Junker K
    Chirurg; 2003 Jan; 74(1):42-8; discussion 49. PubMed ID: 12552404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regression grading of neoadjuvant non-small-cell lung carcinoma treatment].
    Junker K; Thomas M; Schulmann K; Klinke V; Bosse U; Müller KM
    Pathologe; 1997 Mar; 18(2):131-40. PubMed ID: 9244871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M; Chapman R; Kim JH
    Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial.
    Wu KL; Jiang GL; Liao Y; Qian H; Wang LJ; Fu XL; Zhao S
    Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1336-44. PubMed ID: 14630271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoadjuvant radiochemotherapy in locally advanced non-small cell bronchial carcinoma. Initial results of a prospective multicenter study].
    Wagner W; von Eiff M; Klinke F; Micke O; Rübe C; Willich N
    Strahlenther Onkol; 1995 Jul; 171(7):390-7. PubMed ID: 7631260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot study.
    Maggi G; Casadio C; Cianci R; Oliaro A; Molinatti M; Bretti S; Clerico M; Boidi-Trotti A; Rovea P
    J Cardiovasc Surg (Torino); 1994 Aug; 35(4):341-6. PubMed ID: 7929550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative radiochemotherapy and radical resection for stages II to IV oral and oropharyngeal cancer: grade of regression as crucial prognostic factor.
    Klug C; Wutzl A; Kermer C; Ploder O; Sulzbacher I; Selzer E; Voracek M; Oeckher M; Ewers R; Millesi W
    Int J Oral Maxillofac Surg; 2005 May; 34(3):262-7. PubMed ID: 15741034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic assessment of non-small cell lung carcinoma after neoadjuvant therapy.
    Liu-Jarin X; Stoopler MB; Raftopoulos H; Ginsburg M; Gorenstein L; Borczuk AC
    Mod Pathol; 2003 Nov; 16(11):1102-8. PubMed ID: 14614049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy-induced morphological changes in lung cancer].
    Junker K
    Pathologe; 2004 Nov; 25(6):475-80. PubMed ID: 15375632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
    Jain AK; Hughes RS; Sandler AB; Dowlati A; Schwartzberg LS; Dobbs T; Schlabach L; Wu J; Muldowney NJ; Choy H
    J Thorac Oncol; 2009 Jun; 4(6):722-7. PubMed ID: 19404213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy: the prognostic importance of the area of residual tumor.
    Yamane Y; Ishii G; Goto K; Kojima M; Nakao M; Shimada Y; Nishiwaki Y; Nagai K; Kohrogi H; Ochiai A
    J Thorac Oncol; 2010 Jan; 5(1):49-55. PubMed ID: 20035185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies.
    Movsas B; Scott C; Sause W; Byhardt R; Komaki R; Cox J; Johnson D; Lawton C; Dar AR; Wasserman T; Roach M; Lee JS; Andras E
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1143-9. PubMed ID: 10613306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).
    Choy H; Devore RF; Hande KR; Porter LL; Rosenblatt P; Yunus F; Schlabach L; Smith C; Shyr Y; Johnson DH
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):931-7. PubMed ID: 10863062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
    Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
    Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment.
    Maquilan G; Grover S; Xanthopoulos E; Evans TL; Aggarwal C; Langer CJ; Cohen RB; Stevenson JP; Simone CB; Rengan R
    Am J Clin Oncol; 2018 Apr; 41(4):391-395. PubMed ID: 27100960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.